stockrowCONMED Corporation (CNMD) vs Tandem Diabetes Care, Inc. (TNDM)
- CONMED Corporation CNMD 52.01 −1.55%
- Tandem Diabetes Care, Inc. TNDM 16.67 −7.34%
CONMED Corporation and Tandem Diabetes Care, Inc. are both Medical Devices companies. CONMED Corporation is the larger, with a market value of $1.6B against $1.3B — 1.3× the size. Tandem Diabetes Care, Inc. has negative trailing earnings, so its P/E is not meaningful; CONMED Corporation trades at 21.7×. Tandem Diabetes Care, Inc. grew revenue faster over the last twelve months: 6.84% against 1.62%. CONMED Corporation has the higher net margin (5.36% vs −4.58%) and the higher return on invested capital (4.64% vs −5.35%). Across the 19 metrics below, CONMED Corporation leads on 14 and Tandem Diabetes Care, Inc. on 5.
Valuation
Profitability
| Metric | CNMD | TNDM | Medical Devices median |
|---|---|---|---|
| Gross margin | 57.57% | 56.65% | 57.76% |
| Operating margin | 9.90% | (2.35%) | (15.07%) |
| Net margin | 5.36% | (4.58%) | (14.45%) |
| Free cash flow margin | 9.69% | (3.37%) | (3.88%) |
| Return on equity | 7.10% | (36.74%) | (10.35%) |
| Return on assets | 3.17% | (4.84%) | (17.26%) |
| Return on invested capital | 4.64% | (5.35%) | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack